logo
AMERICAN TIRE DISTRIBUTORS A NEW COMPANY WITH COMMITTED OWNERS, EXPERIENCED LEADERSHIP TEAM AND STRONG FINANCIAL POSITION

AMERICAN TIRE DISTRIBUTORS A NEW COMPANY WITH COMMITTED OWNERS, EXPERIENCED LEADERSHIP TEAM AND STRONG FINANCIAL POSITION

HUNTERSVILLE, N.C., March 5, 2025 /PRNewswire/ -- American Tire Distributors, one of the largest independent suppliers in the replacement tire market, has successfully completed a strategic sale of substantially all of its assets. Under the ownership of well-capitalized investors dedicated to achieving long-term success, the new company (the 'New Company') – which plans to do business as American Tire Distributors ('ATD') - is set to accelerate growth and be a leader in the industry.
With a focus on its core tire distribution business, the New Company is committed to its national distribution network to drive efficiency and deliver exceptional value to its manufacturer partners and customers. Backed by a strong financial foundation, the New Company plans to invest significantly in rebuilding inventory and optimizing its distribution footprint, ensuring a seamless and improved experience across its network.
Leading the New Company is an experienced and dynamic leadership team. Ira Silver has been appointed as President and Chief Executive Officer, effective immediately, bringing a fresh vision and strategic direction. Additionally, Sean Franciscus joins as Executive Vice President and Chief Operating Officer, reinforcing the New Company's commitment to operational excellence. In recognition of his contributions in the industry, Keith Calcagno's role within the New Company will be Executive Vice President and Chief Sales Officer.
'With a strong financial position, experienced leadership team, and committed new owners, American Tire Distributors is ready to write its success story,' said Ira Silver, CEO of the New Company. 'We are incredibly grateful for the support we've received and excited to focus on delivering for our manufacturer partners and bringing high-quality products and unparalleled service to our customers.'
Sean Franciscus, COO, added, 'The loyalty of our associates, customers, and core vendors is a testament to the New Company's solid foundation. Now, we turn our attention to building - honoring our commitment to excellence, leveraging our strengths, and claiming our place as the industry leader in wholesale tire distribution.'
With a clear strategy, strong leadership, and unwavering focus on achieving the highest standards, the New Company is paving the way towards a successful, sustainable future.
About American Tire Distributors
American Tire Distributors ('ATD') is one of the nation's largest independent suppliers to the replacement tire industry. With a robust network of over 110 distribution centers, we proudly serve 80,000 customers nationwide. Our extensive inventory and commitment to dependable service are complemented by a suite of value-added services tailored to the tire and automotive service industry.
With a team of nearly 4,000 dedicated associates, ATD is driven by a customer-first mentality. This past year, ATD has been recognized through several prestigious awards, including the Stevie® Award for Sales & Customer Service, and multiple accolades from The American Business Awards®. Notably, ATD received the Gold Stevie® Award for Company of the Year - Automotive & Transport Equipment – Large and the Silver Stevie® Award for Artificial Intelligence/Machine Learning Solution.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Establishment Labs Hosting Investor Day on June 12
Establishment Labs Hosting Investor Day on June 12

Yahoo

time30 minutes ago

  • Yahoo

Establishment Labs Hosting Investor Day on June 12

NEW YORK, June 11, 2025--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, will host its previously announced analyst and investor event in New York City on June 12, 2025 beginning at 1pm ET. A live and archived webcast of presentations and Q&A sessions on June 12 will be available on the "Investors" section of the Establishment Labs website at In-person attendance at the event is limited and requires advanced registration. Please email: ir@ for further information. About Establishment Labs Establishment Labs Holdings Inc. is a global medical device company dedicated to improving women's health and wellness in breast aesthetics and reconstruction through the power of science, engineering, and technology. The Company offers a portfolio of solutions for breast health, breast aesthetics, and breast reconstruction in over 90 countries. With over four million Motiva ® devices delivered to plastic and reconstructive surgeons since 2010, the Company's products have created a new standard for safety and patient satisfaction. The company's minimally invasive platform consists of Mia Femtech®, a unique minimally invasive experience for breast harmonization, and Preservé™, a breast tissue preserving and minimally invasive technology for breast augmentation, revision augmentation and mastopexy augmentation. GEM® is a next generation minimally invasive system for gluteal ergonomic modeling currently undergoing an IRB approved pivotal study. The Motiva Flora® tissue expander is used to improve outcomes in breast reconstruction following breast cancer and is the only regulatory-approved expander in the world with an integrated port using radio-frequency technology that is MRI conditional. Zensor™ is an RFID technology platform used to safely identify implantable devices from outside the body, and includes the company's first biosensor Zen°™, currently part of an IRB approved pivotal study to measure core breast temperature. These solutions are supported by over 200 patent applications in 20 separate patent families worldwide and over 100 scientific and clinical studies and publications in peer reviewed journals. Establishment Labs manufactures at two facilities in Costa Rica compliant with all applicable regulatory standards under ISO13485:2024 and FDA 21 CFR 820. Please visit our website for additional information at View source version on Contacts Investor/Media Contact: Raj Denhoy415 828-1044rdenhoy@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Establishment Labs Hosting Investor Day on June 12
Establishment Labs Hosting Investor Day on June 12

Business Wire

time35 minutes ago

  • Business Wire

Establishment Labs Hosting Investor Day on June 12

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, will host its previously announced analyst and investor event in New York City on June 12, 2025 beginning at 1pm ET. A live and archived webcast of presentations and Q&A sessions on June 12 will be available on the "Investors" section of the Establishment Labs website at In-person attendance at the event is limited and requires advanced registration. Please email: ir@ for further information. About Establishment Labs Establishment Labs Holdings Inc. is a global medical device company dedicated to improving women's health and wellness in breast aesthetics and reconstruction through the power of science, engineering, and technology. The Company offers a portfolio of solutions for breast health, breast aesthetics, and breast reconstruction in over 90 countries. With over four million Motiva ® devices delivered to plastic and reconstructive surgeons since 2010, the Company's products have created a new standard for safety and patient satisfaction. The company's minimally invasive platform consists of Mia Femtech®, a unique minimally invasive experience for breast harmonization, and Preservé™, a breast tissue preserving and minimally invasive technology for breast augmentation, revision augmentation and mastopexy augmentation. GEM® is a next generation minimally invasive system for gluteal ergonomic modeling currently undergoing an IRB approved pivotal study. The Motiva Flora® tissue expander is used to improve outcomes in breast reconstruction following breast cancer and is the only regulatory-approved expander in the world with an integrated port using radio-frequency technology that is MRI conditional. Zensor™ is an RFID technology platform used to safely identify implantable devices from outside the body, and includes the company's first biosensor Zen°™, currently part of an IRB approved pivotal study to measure core breast temperature. These solutions are supported by over 200 patent applications in 20 separate patent families worldwide and over 100 scientific and clinical studies and publications in peer reviewed journals. Establishment Labs manufactures at two facilities in Costa Rica compliant with all applicable regulatory standards under ISO13485:2024 and FDA 21 CFR 820. Please visit our website for additional information at

Moxie and Revision Skincare® Announce Strategic Partnership to Empower High-Growth Medspas
Moxie and Revision Skincare® Announce Strategic Partnership to Empower High-Growth Medspas

Yahoo

timean hour ago

  • Yahoo

Moxie and Revision Skincare® Announce Strategic Partnership to Empower High-Growth Medspas

Streamlined Ordering and Exclusive Education Now Available to Moxie-Supported Practices BROOKLYN, N.Y., June 11, 2025 /PRNewswire/ -- Moxie, the growth engine supporting over 400 aesthetic practices nationwide, today announced a strategic partnership with Revision Skincare®, the gold standard in science-backed, clinically proven skincare. This partnership brings Moxie-supported practices direct access to Revision's line of medical grade skincare, streamlined ordering, and elevated educational resources—all designed to drive profitability, operational efficiency, and exceptional client outcomes. "Independent medspas are the heartbeat of our specialty," said Kamau Massey, CEO of Moxie. "By partnering with Revision Skincare, we're expanding the ways in which we give our practices access to elite-tier products and business tools. It's about helping them compete—and win—at the highest level." This collaboration reflects a shared vision: empowering aesthetic entrepreneurs with the kind of brand alignment, service experience, and margin-boosting resources typically reserved for major enterprise clinics. "Our mission has always been to support skincare professionals with advanced innovation and education," said Joe Blahnik, Chief Sales Officer Revision Skincare®. "Moxie's commitment to the success of aesthetic practices mirrors our own—and together, we're making it easier than ever for providers to deliver exceptional results." This partnership is part of Moxie's ongoing commitment to building a best-in-class ecosystem for medspa success—uniting trusted brands that help independent practices grow, differentiate, and deliver exceptional patient experiences. About Moxie Moxie is the aesthetic practice growth and operating engine, helping medspa entrepreneurs reach multimillion dollar growth—with marketing, compliance, coaching, software, and VIP pricing, all in one place. From launch to scale, Moxie powers ambitious injectors and aesthetic entrepreneurs with the infrastructure, strategy, and partnerships they need to win in a competitive industry. About Revision Skincare® Revision Skincare® delivers high-performing, clinically validated skincare formulations rooted in rigorous research and testing. Trusted by professionals in over thirty countries across the globe, their award-winning products are designed to deliver real results—without compromising long-term skin health. Brandi EppolitoHead of MarketingMoxiebrandi@ This release was issued through WebWire®. For more information, visit View original content: SOURCE Moxie Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store